[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100630590":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":34,"locations":40,"responsibleParty":363,"collaborators":26,"id":365,"slug":366,"hasResults":367,"nctId":368,"briefTitle":369,"officialTitle":370,"acronym":26,"eligibilityCriteria":371,"healthyVolunteers":367,"sex":372,"minAge":373,"maxAge":374,"enrollmentInfo":375,"targetDuration":26,"studyType":378,"phases":379,"briefSummary":381,"conditions":382,"keywords":384,"overallStatus":43,"whyStopped":26,"lastUpdateSubmitDate":386,"lastUpdatePostDateStruct":387,"startDateStruct":390,"completionDateStruct":392,"leadSponsor":394,"locationsCount":395},{"fullName":5,"class":6},"Reunion Neuroscience Inc","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Placebo","PLACEBO_COMPARATOR","A single subcutaneous injection of 0.9% sodium chloride for injection",[13],"Drug: Placebo",{"label":15,"type":16,"description":17,"interventionNames":18},"30 mg RE104","EXPERIMENTAL","A single subcutaneous injection of 30 mg RE104 for Injection",[19],"Drug: RE104 for Injection",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","RE104 for Injection","Single, subcutaneous dose of RE104 for Injection",[15],null,{"type":22,"name":9,"description":28,"armGroupLabels":29,"otherNames":26},"Single, subcutaneous dose of 0.9% sodium chloride for injection",[9],[31],{"name":32,"affiliation":5,"role":33},"Mark Pollack, M.D.","STUDY_DIRECTOR",[35],{"name":36,"role":37,"phone":38,"phoneExt":26,"email":39},"Mark Pollack Chief Medical Officer, M.D.","CONTACT","1-888-880-REUN","info@reunionneuro.com",[41,60,76,91,105,119,132,147,161,176,189,205,220,236,251,265,280,294,309,320,334,349],{"facility":42,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"Lighthouse Psychiatry","RECRUITING","Gilbert","Arizona","85234","United States","US",{"type":50,"coordinates":51},"Point",[52,53],-111.78903,33.35283,{"lat":53,"lon":52},[56],{"name":57,"role":37,"phone":58,"phoneExt":26,"email":59},"Matt Longson","435-268-5800","Contact@neosciclinicalresearch.com",{"facility":61,"status":43,"city":62,"state":63,"zip":64,"country":47,"countryCode":48,"cosmosGeoPoint":65,"geoPoint":69,"contacts":70},"Preferred Research Partners, Inc.","Little Rock","Arkansas","72211",{"type":50,"coordinates":66},[67,68],-92.28959,34.74648,{"lat":68,"lon":67},[71],{"name":72,"role":37,"phone":73,"phoneExt":74,"email":75},"Stacy Tierney","501-553-9987","111","stierney@preferredresearchpartners.com",{"facility":77,"status":43,"city":78,"state":79,"zip":80,"country":47,"countryCode":48,"cosmosGeoPoint":81,"geoPoint":85,"contacts":86},"Collaborative Neuroscience Research, LLC","Garden Grove","California","92845",{"type":50,"coordinates":82},[83,84],-117.94145,33.77391,{"lat":84,"lon":83},[87],{"name":88,"role":37,"phone":89,"phoneExt":26,"email":90},"CNS Outreach Department","844-424-9494","cns.outreach@cenexel.com",{"facility":92,"status":43,"city":93,"state":79,"zip":94,"country":47,"countryCode":48,"cosmosGeoPoint":95,"geoPoint":99,"contacts":100},"Kadima Neuropsychiatry Institute","La Jolla","92037",{"type":50,"coordinates":96},[97,98],-117.2742,32.84727,{"lat":98,"lon":97},[101],{"name":102,"role":37,"phone":103,"phoneExt":26,"email":104},"Angelica Lu","858-775-2053","angelical@kadimanp.com",{"facility":106,"status":43,"city":107,"state":79,"zip":108,"country":47,"countryCode":48,"cosmosGeoPoint":109,"geoPoint":113,"contacts":114},"Open Mind Therapeutics","San Francisco","94114",{"type":50,"coordinates":110},[111,112],-122.41942,37.77493,{"lat":112,"lon":111},[115],{"name":116,"role":37,"phone":117,"phoneExt":26,"email":118},"Victoria Vega","415-906-7399","victoria@openmindcollective.org",{"facility":120,"status":43,"city":121,"state":79,"zip":122,"country":47,"countryCode":48,"cosmosGeoPoint":123,"geoPoint":127,"contacts":128},"TRIP Clinic at Psychedelic Science Institute","Santa Monica","90404",{"type":50,"coordinates":124},[125,126],-118.49138,34.01949,{"lat":126,"lon":125},[129],{"name":130,"role":37,"phone":26,"phoneExt":26,"email":131},"Ashley Ramos","trialadmin@psychedlicsci.com",{"facility":133,"status":43,"city":134,"state":135,"zip":136,"country":47,"countryCode":48,"cosmosGeoPoint":137,"geoPoint":141,"contacts":142},"Innovative Clinical Research, Inc.","Lauderhill","Florida","33319",{"type":50,"coordinates":138},[139,140],-80.21338,26.14036,{"lat":140,"lon":139},[143],{"name":144,"role":37,"phone":145,"phoneExt":26,"email":146},"Melissa Rodco","305-722-8444","mrodco@segaltrials.com",{"facility":148,"status":43,"city":149,"state":135,"zip":150,"country":47,"countryCode":48,"cosmosGeoPoint":151,"geoPoint":155,"contacts":156},"University of South Florida","Tampa","33613",{"type":50,"coordinates":152},[153,154],-82.45843,27.94752,{"lat":154,"lon":153},[157],{"name":158,"role":37,"phone":159,"phoneExt":26,"email":160},"Genesis Estramera","813-974-1404","gestramera@usf.edu",{"facility":162,"status":43,"city":163,"state":164,"zip":165,"country":47,"countryCode":48,"cosmosGeoPoint":166,"geoPoint":170,"contacts":171},"Atlanta Center for Medical Research","Atlanta","Georgia","30331",{"type":50,"coordinates":167},[168,169],-84.38798,33.749,{"lat":169,"lon":168},[172],{"name":173,"role":37,"phone":174,"phoneExt":26,"email":175},"Amber Tannahill","404-881-5800","a.tannahill@cenexel.com",{"facility":177,"status":43,"city":178,"state":164,"zip":179,"country":47,"countryCode":48,"cosmosGeoPoint":180,"geoPoint":184,"contacts":185},"CenExel iResearch, LLC","Decatur","30030",{"type":50,"coordinates":181},[182,183],-84.29631,33.77483,{"lat":183,"lon":182},[186],{"name":187,"role":37,"phone":26,"phoneExt":26,"email":188},"Michael Mahaffrey","m.mahaffrey@cenexel.com",{"facility":190,"status":43,"city":191,"state":192,"zip":193,"country":47,"countryCode":48,"cosmosGeoPoint":194,"geoPoint":198,"contacts":199},"Uptown Research Institute","Chicago","Illinois","60640",{"type":50,"coordinates":195},[196,197],-87.65005,41.85003,{"lat":197,"lon":196},[200],{"name":201,"role":37,"phone":202,"phoneExt":203,"email":204},"Deborah Jones-Miller","773-989-8313","117","Djones-miller@uptownresearch.com",{"facility":206,"status":43,"city":207,"state":208,"zip":209,"country":47,"countryCode":48,"cosmosGeoPoint":210,"geoPoint":214,"contacts":215},"Henry Ford Medical Center - Columbus","Novi","Michigan","48377",{"type":50,"coordinates":211},[212,213],-83.47549,42.48059,{"lat":213,"lon":212},[216],{"name":217,"role":37,"phone":218,"phoneExt":26,"email":219},"Madeline Bross","248-344-7366","mbross1@hfhs.org",{"facility":221,"status":43,"city":222,"state":223,"zip":224,"country":47,"countryCode":48,"cosmosGeoPoint":225,"geoPoint":229,"contacts":230},"Midwest Research Group","Saint Charles","Missouri","63304",{"type":50,"coordinates":226},[227,228],-90.48123,38.78394,{"lat":228,"lon":227},[231],{"name":232,"role":37,"phone":233,"phoneExt":234,"email":235},"Lindsay vanWinkle","636-946-8032","3","lvanwinkle@midwestresearchgroup.com",{"facility":237,"status":43,"city":238,"state":239,"zip":240,"country":47,"countryCode":48,"cosmosGeoPoint":241,"geoPoint":245,"contacts":246},"UNM Research Program Psychedelic Therapies","Albuquerque","New Mexico","14624",{"type":50,"coordinates":242},[243,244],-106.65114,35.08449,{"lat":244,"lon":243},[247],{"name":248,"role":37,"phone":249,"phoneExt":26,"email":250},"Hector Garcia","505-675-0582","hecgarcia@salud.unm.edu",{"facility":252,"status":43,"city":253,"state":253,"zip":254,"country":47,"countryCode":48,"cosmosGeoPoint":255,"geoPoint":259,"contacts":260},"NYU-H+C Clinical and Translational Science Institute","New York","10016",{"type":50,"coordinates":256},[257,258],-74.00597,40.71427,{"lat":258,"lon":257},[261],{"name":262,"role":37,"phone":263,"phoneExt":26,"email":264},"Jillian Kelly","212-404-7764","Jillian.kelly@nyulangone.org",{"facility":266,"status":43,"city":267,"state":268,"zip":269,"country":47,"countryCode":48,"cosmosGeoPoint":270,"geoPoint":274,"contacts":275},"Neuro-Behavioral Clinical Research, Inc.","North Canton","Ohio","44720",{"type":50,"coordinates":271},[272,273],-81.40234,40.87589,{"lat":273,"lon":272},[276],{"name":277,"role":37,"phone":278,"phoneExt":26,"email":279},"Crystal Blackford","330-493-1118","cblackford@nb-cr.com",{"facility":281,"status":43,"city":282,"state":283,"zip":284,"country":47,"countryCode":48,"cosmosGeoPoint":285,"geoPoint":289,"contacts":290},"Summit Headlands LLC","Portland","Oregon","97210",{"type":50,"coordinates":286},[287,288],-122.67621,45.52345,{"lat":288,"lon":287},[291],{"name":292,"role":37,"phone":26,"phoneExt":26,"email":293},"Tyler Leecing","tyler.leecing@summitnetwork.com",{"facility":295,"status":43,"city":296,"state":297,"zip":298,"country":47,"countryCode":48,"cosmosGeoPoint":299,"geoPoint":303,"contacts":304},"Austin Clinical Trial Partners","Austin","Texas","78737",{"type":50,"coordinates":300},[301,302],-97.74306,30.26715,{"lat":302,"lon":301},[305],{"name":306,"role":37,"phone":307,"phoneExt":26,"email":308},"Kara Chilek","512-521-0595","studyinfo@austinCTP.com",{"facility":310,"status":43,"city":296,"state":297,"zip":311,"country":47,"countryCode":48,"cosmosGeoPoint":312,"geoPoint":314,"contacts":315},"BioBehavioral Research Austion","78759",{"type":50,"coordinates":313},[301,302],{"lat":302,"lon":301},[316],{"name":317,"role":37,"phone":318,"phoneExt":26,"email":319},"Tracie Wesson","402-934-0044","tracie.wesson@qcrnetwork.com",{"facility":321,"status":43,"city":322,"state":297,"zip":323,"country":47,"countryCode":48,"cosmosGeoPoint":324,"geoPoint":328,"contacts":329},"Aim Trials, LLC","Plano","75093",{"type":50,"coordinates":325},[326,327],-96.69889,33.01984,{"lat":327,"lon":326},[330],{"name":331,"role":37,"phone":332,"phoneExt":26,"email":333},"Sonia Prashar","214-856-2778","sonia.prashar@aimtrials.com",{"facility":335,"status":43,"city":336,"state":337,"zip":338,"country":47,"countryCode":48,"cosmosGeoPoint":339,"geoPoint":343,"contacts":344},"Cedar Clinical Research","Draper","Utah","84020",{"type":50,"coordinates":340},[341,342],-111.86382,40.52467,{"lat":342,"lon":341},[345],{"name":346,"role":37,"phone":347,"phoneExt":26,"email":348},"Jane Bjorklund","801-369-4219","jane.bjorklund@numinusnetwork.com",{"facility":350,"status":43,"city":351,"state":337,"zip":352,"country":47,"countryCode":48,"cosmosGeoPoint":353,"geoPoint":357,"contacts":358},"Inner Space State Street","Orem","84058",{"type":50,"coordinates":354},[355,356],-111.69465,40.2969,{"lat":356,"lon":355},[359],{"name":360,"role":37,"phone":361,"phoneExt":26,"email":362},"Janet Jimenez","801-871-5516","apply@innerspaceresearch.com",{"type":364,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100630590","phase-2-re104-safety-and-efficacy-study-in-generalized-anxiety-disorder-100630590",false,"NCT07489651","RE104 Safety and Efficacy Study in Generalized Anxiety Disorder","A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Generalized Anxiety Disorder","Inclusion Criteria:\n\n* Has Generalized Anxiety Disorder as defined by DSM-5-TR\n* If female is not pregnant or planning to become pregnant. If male is not planning to make a partner pregnant.\n* Is willing and able to comply with the conditions and requirements of the study\n\nExclusion Criteria:\n\n* Has a significant risk of suicide\n* Has an active or medical history of bipolar disorder, schizophrenia, schizoaffective disorder, psychotic disorder and\u002For borderline personality disorder, or first-degree family history of psychosis or bipolar disorder\n* Has other concurrent psychiatric disorders that is the primary disorder.\n* Has other medically significant conditions rendering unsuitability for the study\n* Has used or will need to use prohibited medications or therapies\n* Has a known sensitivity or intolerance to study intervention or potential rescue medications","ALL","18 Years","74 Years",{"count":376,"type":377},64,"ESTIMATED","INTERVENTIONAL",[380],"PHASE2","The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces anxiety symptoms in participants with Generalized Anxiety Disorder (GAD) as compared to placebo.",[383],"Generalized Anxiety Disorder",[385],"GAD","2026-06-23",{"date":388,"type":389},"2026-06-26","ACTUAL",{"date":391,"type":389},"2026-04-20",{"date":393,"type":377},"2027-04",{"name":5,"class":6},22]